Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118319) titled 'Investigation of the impact of dietary habits and gut microbiota on the efficacy of immunotherapy in cancer patients' on Feb. 4.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Condition:
Patients with colorectal cancer
patients undergoing immunotherapy for malignant tumors
Intervention:
Patients with colorectal cancer:none
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-03-25
Target Sample Size: Patients with colorectal cancer:150;Patients undergoing immunotherapy fo...